Barriers to compliance with prophylaxis therapy in haemophilia

被引:234
|
作者
Hacker, MR [1 ]
Geraghty, S [1 ]
Manco-Johnson, M [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA
关键词
children; compliance; haemophilia; prophylaxis;
D O I
10.1046/j.1365-2516.2001.00534.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prophylaxis, or the practice of routine replacement infusions of clotting factor concentrate in persons with severe haemophilia, is a demanding medical regimen. Prophylactic infusions require direct venepuncture or sterile entry into a central venous access device on a regular basis. A telephone survey was conducted to elicit information regarding the barriers to compliance with prophylaxis. The Mountain States Regional Haemophilia and Thrombosis Center has recommended prophylaxis to 52 male patients with haemophilia A or B. The haemophilia nurse attempted to contact all of these patients or their parents, and contact was made with 38 (73.1%) of them. Respondents were asked about the following issues: their decision to initiate prophylaxis; their self-rated compliance; the challenges, barriers, and facilitators of prophylaxis; and their perceived value of the therapy. Four patients (10.5%) elected not to begin prophylaxis. Of the 34 persons who began prophylaxis, 20 respondents (58.8%) rated their compliance as excellent. Nearly one-third of the families with excellent compliance (giving 75-100% of prescribed infusions) stated that the time-consuming nature of prophylaxis was the most significant challenge of the regimen. In addition, 58.3% of the families that gave less than the prescribed number of infusions reported that the time commitment was the primary reason for missing infusions. Knowledge of the benefits of prophylaxis was the primary facilitator of compliance for 44.1% of families. Ninety-seven percent of respondents rated prophylaxis as very valuable. These data show that despite the known benefits of prophylaxis, it is a demanding medical regimen, and compliance is imperfect. In addition, this study underscores the importance of providing continuing support and education for patients and families who are implementing prophylaxis.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 50 条
  • [21] Prophylaxis in adult patients with severe haemophilia A
    Oldenburg, Johannes
    Brackmann, Hans-Hermann
    THROMBOSIS RESEARCH, 2014, 134 : S33 - S37
  • [22] Haemophilia prophylaxis in paediatrics
    Harroche, Annie
    Meunier, Sandrine
    HEMATOLOGIE, 2024, 30 (06):
  • [23] Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
    Lindvall, K
    Colstrup, L
    Wollter, IM
    Klemenz, G
    Loogna, K
    Grönhaug, S
    Thykjaer, H
    HAEMOPHILIA, 2006, 12 (01) : 47 - 51
  • [24] Low-dose prophylaxis and its impact on the health of haemophilia patients
    Shetty, Shrimati
    Bansal, Shweta
    Kshirsagar, Shrinath
    Rangarajan, Savita
    Hajirnis, Kalpana
    Phadke, Varsha
    VOX SANGUINIS, 2022, 117 (07) : 900 - 912
  • [25] Monitoring people with haemophilia on low dose prophylaxis with haemophilia joint health score
    Zgoulli, Ahmed
    Ghali, Ons
    Zahra, Kaouther
    Achour, Mariem
    Gouider, Emna
    HAEMOPHILIA, 2024, 30 : 126 - 126
  • [26] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    HAEMOPHILIA, 2020, 26 (01) : 41 - 46
  • [27] Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis
    Daffunchio, Carla
    Galatro, Gustavo
    Rossi, Martin
    Landro, Maria
    Andreu, Mauro
    Neme, Daniela
    Caviglia, Horacio
    HAEMOPHILIA, 2021, 27 (04) : 641 - 647
  • [28] Low dose prophylaxis in Tunisian children with haemophilia
    Gouider, E.
    Jouini, L.
    Achour, M.
    Elmahmoudi, H.
    Zahra, K.
    Saied, W.
    Meddeb, B.
    HAEMOPHILIA, 2017, 23 (01) : 77 - 81
  • [29] Unravelling adherence to prophylaxis in haemophilia: a patients' perspective
    Schrijvers, L. H.
    Kars, M. C.
    Beijlevelt-van der Zande, M.
    Peters, M.
    Schuurmans, M. J.
    Fischer, K.
    HAEMOPHILIA, 2015, 21 (05) : 612 - 621
  • [30] Experience of prophylaxis treatment in children with severe haemophilia
    Yee, TT
    Beeton, K
    Griffioen, A
    Harrington, C
    Miners, A
    Lee, CA
    Brown, SA
    HAEMOPHILIA, 2002, 8 (02) : 76 - 82